Expert insight from Brendan Frey, Founder and Chief Innovation Officer at Deep Genomics.
We've all heard of and used ChatGPT. But what if we could apply this to pharmaceutical research and development? Effectively using AI for business and patient outcomes requires fundamental technical, cultural and organizational change.
While most previous efforts to use AI for drug discovery have failed, over the past two years AI has made dramatic advances that could transform the pharmaceutical industry. AI-based models have demonstrated the potential to accelerate drug discovery, optimize clinical trials, and even help predict side effects.
This article is available to registered users only. To continue reading, please sign up for free. Your free trial will give you one week of exclusive features, interviews, roundups and commentary from some of the sharpest minds in the pharma and biotech sector. If you're already a registered user, please log in. If your trial has expired, you can sign up here.
Log in to your account
Try before you buy
free
7-day trial access
Start your free trial
- News affecting the pharmaceutical and biotechnology industries
- Exclusive features, podcasts, interviews, data analysis and commentary from a global network of life sciences journalists.
- Receive The Pharma Letter's daily breaking news bulletin free forever.
Become a subscriber
£820
Or £77 per month
Subscribe now
- Your free access to leading pharma and biotech news, commentary and analysis.
- Updates on clinical trials, conferences, M&A, licensing, funding, regulatory, patent and legal affairs, executive appointments, commercial strategies and financial results.
- A daily roundup of major pharma and biotech events.
- Detailed monthly reports on executive changes and M&A news.
- Choose from cost-effective annual packages or flexible monthly subscriptions
Pharma Letter is an extremely useful and valuable life sciences service that brings you a daily roundup of performance, people and product updates – some of the key pieces of information to help you stay up to date.
Chairman of Sanofi-Aventis UK
